The amplification was associated with BC recurrence and poor prognosis, and genes within 1q23.1 contributed to BC progression, including S100A7, S100A8, S100A9, and IRK1 (IL-1 receptor-associated kinase 1) [29]. This evidence concerns the gene S100A9 and breast cancer.